Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	spectrin-associated cytoskeleton	ANK3 SPTB SPTBN1	3.11e-06	9	71	3	GO:0014731
GeneOntologyCellularComponent	cell cortex	ZHX3 FRY CDC42SE1 SPTB SPTBN1 MYO1F PKD2 FRYL ACTN3	4.48e-06	371	71	9	GO:0005938
GeneOntologyCellularComponent	autolysosome membrane	HLA-DRB1 HLA-DRB3	6.79e-05	4	71	2	GO:0120281
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-DRB1 HLA-DRB3 PKD2	2.27e-04	35	71	3	GO:0098553
GeneOntologyCellularComponent	cortical actin cytoskeleton	SPTB SPTBN1 MYO1F ACTN3	2.84e-04	93	71	4	GO:0030864
GeneOntologyCellularComponent	spectrin	SPTB SPTBN1	4.03e-04	9	71	2	GO:0008091
GeneOntologyCellularComponent	lumenal side of membrane	HLA-DRB1 HLA-DRB3 PKD2	5.82e-04	48	71	3	GO:0098576
GeneOntologyCellularComponent	COPI vesicle coat	COPA SCYL1	8.66e-04	13	71	2	GO:0030126
GeneOntologyCellularComponent	cortical cytoskeleton	SPTB SPTBN1 MYO1F ACTN3	9.77e-04	129	71	4	GO:0030863
GeneOntologyCellularComponent	spindle	FRY CEP250 PKD2 IRAG2 DIDO1 ESPL1 DSN1	1.08e-03	471	71	7	GO:0005819
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	ABCA3 MALRD1 COPA SLC17A9 INPP4A HLA-DRB1 HLA-DRB3 PKD2 IRAG2 SCYL1 RND2 NOS3	1.40e-03	1307	71	12	GO:0030659
GeneOntologyCellularComponent	MHC class II protein complex	HLA-DRB1 HLA-DRB3	1.50e-03	17	71	2	GO:0042613
GeneOntologyCellularComponent	vesicle membrane	ABCA3 MALRD1 COPA SLC17A9 INPP4A HLA-DRB1 HLA-DRB3 PKD2 IRAG2 SCYL1 RND2 NOS3	1.57e-03	1325	71	12	GO:0012506
GeneOntologyCellularComponent	autolysosome	HLA-DRB1 HLA-DRB3	1.68e-03	18	71	2	GO:0044754
GeneOntologyCellularComponent	COPI-coated vesicle membrane	COPA SCYL1	1.87e-03	19	71	2	GO:0030663
GeneOntologyCellularComponent	costamere	ANK3 SVIL	2.51e-03	22	71	2	GO:0043034
Domain	Cell_morpho_N	FRY FRYL	1.47e-05	2	72	2	IPR025614
Domain	MOR2-PAG1_mid	FRY FRYL	1.47e-05	2	72	2	IPR029473
Domain	MOR2-PAG1_mid	FRY FRYL	1.47e-05	2	72	2	PF14228
Domain	MOR2-PAG1_C	FRY FRYL	1.47e-05	2	72	2	PF14225
Domain	MOR2-PAG1_N	FRY FRYL	1.47e-05	2	72	2	PF14222
Domain	Cell_Morphogen_C	FRY FRYL	1.47e-05	2	72	2	IPR025481
Domain	DUF3498	DAB2IP RASAL2	4.39e-05	3	72	2	IPR021887
Domain	DUF3498	DAB2IP RASAL2	4.39e-05	3	72	2	PF12004
Domain	Spectrin_bsu	SPTB SPTBN1	8.75e-05	4	72	2	IPR016343
Domain	Actinin_actin-bd_CS	SPTB SPTBN1 ACTN3	9.20e-05	23	72	3	IPR001589
Domain	Spectrin	SPTB SPTBN1 ACTN3	9.20e-05	23	72	3	PF00435
Domain	ACTININ_2	SPTB SPTBN1 ACTN3	9.20e-05	23	72	3	PS00020
Domain	ACTININ_1	SPTB SPTBN1 ACTN3	9.20e-05	23	72	3	PS00019
Domain	Spectrin_repeat	SPTB SPTBN1 ACTN3	1.87e-04	29	72	3	IPR002017
Domain	Spectrin/alpha-actinin	SPTB SPTBN1 ACTN3	2.51e-04	32	72	3	IPR018159
Domain	SPEC	SPTB SPTBN1 ACTN3	2.51e-04	32	72	3	SM00150
Domain	MHC_II_b_N	HLA-DRB1 HLA-DRB3	4.04e-04	8	72	2	PD000328
Domain	MHC_II_beta	HLA-DRB1 HLA-DRB3	5.18e-04	9	72	2	PF00969
Domain	MHC_II_b_N	HLA-DRB1 HLA-DRB3	5.18e-04	9	72	2	IPR000353
Domain	MHC_II_beta	HLA-DRB1 HLA-DRB3	5.18e-04	9	72	2	SM00921
Domain	RasGAP	DAB2IP RASAL2	1.29e-03	14	72	2	SM00323
Domain	MHC_II_a/b_N	HLA-DRB1 HLA-DRB3	1.29e-03	14	72	2	IPR014745
Domain	-	HLA-DRB1 HLA-DRB3	1.29e-03	14	72	2	3.10.320.10
Domain	RasGAP_CS	DAB2IP RASAL2	1.29e-03	14	72	2	IPR023152
Domain	RasGAP	DAB2IP RASAL2	1.49e-03	15	72	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	DAB2IP RASAL2	1.49e-03	15	72	2	PS00509
Domain	RAS_GTPASE_ACTIV_2	DAB2IP RASAL2	1.49e-03	15	72	2	PS50018
Domain	-	DAB2IP RASAL2	1.70e-03	16	72	2	1.10.506.10
Domain	C2	DAB2IP PIK3C2B INPP4A RASAL2	1.94e-03	137	72	4	SM00239
Domain	CH	SPTB SPTBN1 ACTN3	2.02e-03	65	72	3	SM00033
Domain	RasGAP_dom	DAB2IP RASAL2	2.15e-03	18	72	2	IPR001936
Domain	C2	DAB2IP PIK3C2B INPP4A RASAL2	2.21e-03	142	72	4	PS50004
Domain	CH	SPTB SPTBN1 ACTN3	2.50e-03	70	72	3	PF00307
Domain	-	DAB2IP PIK3C2B INPP4A RASAL2	2.57e-03	148	72	4	2.60.40.150
Domain	-	SPTB SPTBN1 ACTN3	2.60e-03	71	72	3	1.10.418.10
Domain	TPR-contain_dom	TRANK1 SMG7 TONSL EMC2	2.69e-03	150	72	4	IPR013026
Domain	CH	SPTB SPTBN1 ACTN3	2.82e-03	73	72	3	PS50021
Domain	CH-domain	SPTB SPTBN1 ACTN3	3.04e-03	75	72	3	IPR001715
Domain	C2_dom	DAB2IP PIK3C2B INPP4A RASAL2	3.71e-03	164	72	4	IPR000008
Domain	TPR_REGION	TRANK1 SMG7 TONSL EMC2	3.79e-03	165	72	4	PS50293
Domain	TPR	TRANK1 SMG7 TONSL EMC2	3.79e-03	165	72	4	PS50005
Domain	Rho_GTPase_activation_prot	DAB2IP STARD8 RASAL2	4.77e-03	88	72	3	IPR008936
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	ANK3 SPTB SPTBN1	1.10e-06	10	74	3	22159418
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DAB2IP STARD8 ANK3 BRAF SLC17A9 SPTBN1 PEG3 OGDHL DIDO1 FRYL GCNT2 ESPL1	2.93e-06	1084	74	12	11544199
Pubmed	Paediatric celiac patients carrying the HLA-DR7-DQ2 and HLA-DR3-DQ2 haplotypes display small clinical differences.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	24628273
Pubmed	Mutations and selection in the generation of class II histocompatibility antigen polymorphism.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	6589154
Pubmed	Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.	BRAF PKD2	4.47e-06	2	74	2	19098310
Pubmed	Clinical variability and probable founder effect in oculocutaneous albinism type 7.	MALRD1 IRAG2	4.47e-06	2	74	2	31694064
Pubmed	DRB1*03 diversity and DRB3 associations in five major population groups in the United States.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	11872240
Pubmed	A cellular and functional split in the DRw8 haplotype is due to a single amino acid replacement (DR beta ser 57- asp 57).	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	2497068
Pubmed	Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers.	DAB2IP RASAL2	4.47e-06	2	74	2	27974415
Pubmed	The conundrum of HLA-DRB114:01/14:54 and HLA-DRB302:01/02:02 mismatches in unrelated hematopoietic SCT.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	20972469
Pubmed	Development of a new HLA-DRB real-time PCR typing method.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	15620466
Pubmed	Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	16320316
Pubmed	Description of two new HLA-DRB alleles (DRB10310 and DRB301012) found in a Spanish infant.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	9234492
Pubmed	Tracking antigen-specific T-cells during clinical tolerance induction in humans.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	20543955
Pubmed	Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	16200610
Pubmed	HLA-DRB115:01 and HLA-DRB302:02 in PLA2R-Related Membranous Nephropathy.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	28028136
Pubmed	HLA-DRB1 and -DRB3 allele frequencies and haplotypic associations in Koreans.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	15041167
Pubmed	The unusual DRB108:01 haplotype carrying DRB302:02 confirmed in a Dutch family.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	23742216
Pubmed	Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	30282837
Pubmed	Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of human bronchial epithelial cells.	ANK3 SPTBN1	4.47e-06	2	74	2	17074766
Pubmed	[An evaluation of HLA class 2 alleles and anti-islet antibodies as evidence for non-autoimmune diabetes in Wolfram syndrome].	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	21447263
Pubmed	HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	21484216
Pubmed	ERK5 is activated by oncogenic BRAF and promotes melanoma growth.	BRAF MAPK7	4.47e-06	2	74	2	29483645
Pubmed	The mouse zinc-fingers and homeoboxes (ZHX) family; ZHX2 forms a heterodimer with ZHX3.	ZHX3 ZHX2	4.47e-06	2	74	2	14659886
Pubmed	Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	18258695
Pubmed	Molecular, serological and genetic studies on two new HLA-DRB1 alleles--HLA-DRB10704 and HLA-DRB11507.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	11144299
Pubmed	Two novel DRB alleles detected by PCR-SSO and confirmed by sequencing: DRB10317 and DRB30210.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	11169247
Pubmed	HLA-DRB103, DRB111 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	11169267
Pubmed	DRB1*14 diversity and DRB3 associations in four major population groups in the United States.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	12144619
Pubmed	Three new DRB alleles routinely identified by sequence-based typing: DRB1010103, DRB10326 and DRB3*0219.	HLA-DRB1 HLA-DRB3	4.47e-06	2	74	2	15496209
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ZHX3 CACTIN BRAF COPA KDM5C SPTBN1 SVIL DIDO1 ESPL1 STRIP1	5.59e-06	774	74	10	15302935
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	DAB2IP SMG7 COPA PIK3C2B SLC7A6OS SSX2IP SCYL1 GRB10 MAPK7 ESPL1 SOX13	1.19e-05	1038	74	11	26673895
Pubmed	A new spectrin, beta IV, has a major truncated isoform that associates with promyelocytic leukemia protein nuclear bodies and the nuclear matrix.	SPTB SPTBN1	1.34e-05	3	74	2	11294830
Pubmed	A novel DRB3 allele (DRB30208), a new allelic variant of DRB11502 (DRB115023) and two new DQB1 (DQB103012 and DQB1*0614) alleles.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	9802612
Pubmed	Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos.	ANK3 SPTBN1	1.34e-05	3	74	2	17620337
Pubmed	HLA-DR genotypes influence age at disease onset in children and juveniles with type 1 diabetes mellitus.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	20371654
Pubmed	Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	16815190
Pubmed	Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	10609818
Pubmed	Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	15531903
Pubmed	Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma.	ZHX3 ZHX2	1.34e-05	3	74	2	28152006
Pubmed	HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	2471740
Pubmed	Molecular analysis of the HLA class II genes in two DRw6-related haplotypes, DRw13 DQw1 and DRw14 DQw3.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	2493052
Pubmed	Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	18537178
Pubmed	Re-evaluation of DRB10702: evidence for only one allele, DRB10701, encoding the beta chain of the HLA-DR7 antigen.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	8016840
Pubmed	Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	8775462
Pubmed	β spectrin-dependent and domain specific mechanisms for Na+ channel clustering.	SPTB SPTBN1	1.34e-05	3	74	2	32425157
Pubmed	Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	20395221
Pubmed	Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	12694584
Pubmed	Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	8462990
Pubmed	Polymorphism of HLA-DR beta chains in DR4, -7, and -9 haplotypes: implications for the mechanisms of allelic variation.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	3466180
Pubmed	Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	17583734
Pubmed	HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	17050030
Pubmed	Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis.	HLA-DRB1 NOS3	1.34e-05	3	74	2	19327239
Pubmed	Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	20331476
Pubmed	Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation.	BRAF MAPK7	1.34e-05	3	74	2	26959608
Pubmed	The complete amino acid sequence for brain beta spectrin (beta fodrin): relationship to globin sequences.	SPTB SPTBN1	1.34e-05	3	74	2	8479293
Pubmed	The association of HLA-DQB1, -DQA1 and -DPB1 alleles with anti- glomerular basement membrane (GBM) disease in Chinese patients.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	21569485
Pubmed	A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL.	HLA-DRB1 HLA-DRB3	1.34e-05	3	74	2	12008082
Pubmed	Developmental expression of brain beta-spectrin isoform messenger RNAs.	SPTB SPTBN1	1.34e-05	3	74	2	1467942
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	DAB2IP ANK3 SPTBN1 NLGN2 RASAL2 CNTN1	1.64e-05	251	74	6	27507650
Pubmed	The C. elegans homolog of human panic-disorder risk gene TMEM132D orchestrates neuronal morphogenesis through the WAVE-regulatory complex.	TMEM132D SVIL CCDC85A CNTN1	1.74e-05	72	74	4	33726789
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	BRAF CEP250 SPTBN1 SVIL FRYL RASAL2	1.79e-05	255	74	6	15324660
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DAB2IP RSBN1 ZHX3 PEG3 GRB10 ZHX2 STRIP1	2.62e-05	407	74	7	12693553
Pubmed	Evidence for association between the HLA-DQA locus and abdominal aortic aneurysms in the Belgian population: a case control study.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	16879749
Pubmed	Allelic variation in the DR subregion of the human major histocompatibility complex.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	3476943
Pubmed	PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5.	MAPK7 NOS3	2.67e-05	4	74	2	20538799
Pubmed	Genetic susceptibility to breast cancer: HLA DQB03032 and HLA DRB111 may represent protective alleles.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	11027344
Pubmed	HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	14677183
Pubmed	Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	19922436
Pubmed	Additional sequence analysis outside exon 2 clarifies DRB112 and DRB114 allelic frequencies in Koreans.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	19286445
Pubmed	Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	32341563
Pubmed	Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	26740600
Pubmed	Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB11501-DQB10602--positive subjects.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	17002906
Pubmed	The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation.	SPTB SPTBN1	2.67e-05	4	74	2	21566095
Pubmed	Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin.	SPTB SPTBN1	2.67e-05	4	74	2	3862089
Pubmed	Apparent structural differences at the tetramerization region of erythroid and nonerythroid beta spectrin as discriminated by phage displayed scFvs.	SPTB SPTBN1	2.67e-05	4	74	2	21412925
Pubmed	HLA-DRB alleles and systemic lupus erythematosus in Jamaicans.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	12144077
Pubmed	Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	18520346
Pubmed	Sodium channel beta1 subunit-mediated modulation of Nav1.2 currents and cell surface density is dependent on interactions with contactin and ankyrin.	ANK3 CNTN1	2.67e-05	4	74	2	14761957
Pubmed	HLA DR B104, 07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	15795121
Pubmed	Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	11182227
Pubmed	HLA molecules and nasal carriage of Staphylococcus aureus isolated from dialysis and kidney transplant patients at a hospital in Southern Brazil.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	22321387
Pubmed	Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site.	SPTB SPTBN1	2.67e-05	4	74	2	12820899
Pubmed	Molecular analysis of human class II transplantation antigens and their genes.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	6415003
Pubmed	Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.	HLA-DRB1 HLA-DRB3	2.67e-05	4	74	2	15496200
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DAB2IP FRY ANK3 SPTBN1 SVIL DIDO1 NLGN2 RASAL2 CNTN1 STRIP1	3.65e-05	963	74	10	28671696
Pubmed	The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	7477400
Pubmed	HLA class II amino acid epitopes as susceptibility markers of sarcoidosis.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	17559577
Pubmed	Antinuclear antibodies and HLA class II alleles in Jamaican patients with systemic lupus erythematosus.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	17910142
Pubmed	Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	16973583
Pubmed	ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome.	ZHX3 ZHX2	4.45e-05	5	74	2	17056598
Pubmed	Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	1970352
Pubmed	Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	7645219
Pubmed	A comparison of HLA-DR and -DQ allele and haplotype frequencies in Trinidadian populations of African, South Asian, and mixed ancestry.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	12392858
Pubmed	Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	15908298
Pubmed	HLA-DQ8 and the HLA-DQ8-DR4 haplotype are positively associated with the hevein-specific IgE immune response in health care workers with latex allergy.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	12209103
Pubmed	The role of HLA molecules in susceptibility to chronic rheumatic heart disease.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	16426242
Pubmed	HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	17182961
Pubmed	HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	17763415
Pubmed	NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.	HLA-DRB1 HLA-DRB3	4.45e-05	5	74	2	11782380
GeneFamily	EF-hand domain containing\|Spectrins	SPTB SPTBN1	1.82e-04	7	54	2	1113
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	DAB2IP RASAL2	3.88e-04	10	54	2	830
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX3 ZHX2	8.97e-04	15	54	2	529
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	SPTB SPTBN1 GRB10 RASAL2	3.32e-03	206	54	4	682
Coexpression	KOYAMA_SEMA3B_TARGETS_DN	RSBN1 BRAF CDC42SE1 SVIL PEG3 DNAJC21 RASAL2 ATL1	8.69e-06	364	74	8	M2029
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 SPTBN1 ZNF521 GRB10 NOS3 RASAL2	3.66e-08	198	73	7	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 GRB10 CCDC85A RASAL2	4.98e-07	179	73	6	8f9e538c822940785130297712b75131812a4603
ToppCell	facs-Heart-RV-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP FRY PIK3C2B NOS3 CCDC85A RASAL2	7.27e-07	191	73	6	84ebb9f8e975acc88aa600c08a8aa791256948a6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 GRB10 NOS3 RASAL2	7.96e-07	194	73	6	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 ZNF521 NOS3 CCDC85A RASAL2	7.96e-07	194	73	6	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 GRB10 NOS3 RASAL2	7.96e-07	194	73	6	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 GRB10 NOS3 RASAL2	7.96e-07	194	73	6	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 SPTBN1 ZNF521 NOS3 CCDC85A	8.45e-07	196	73	6	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 GRB10 CCDC85A RASAL2	8.45e-07	196	73	6	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 SPTBN1 ZNF521 NOS3 CCDC85A	8.45e-07	196	73	6	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 GRB10 CCDC85A RASAL2	8.45e-07	196	73	6	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 ZNF521 GRB10 NOS3 CCDC85A RASAL2	8.71e-07	197	73	6	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 GRB10 NOS3 RASAL2	8.97e-07	198	73	6	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 SPTBN1 ZNF521 GRB10 NOS3 RASAL2	8.97e-07	198	73	6	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PIK3C2B SPTBN1 ZNF521 GRB10 NOS3 CCDC85A	8.97e-07	198	73	6	8689090bce9ab6e8f122426a404037e572c6713b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 SPTBN1 ZNF521 GRB10 NOS3 RASAL2	8.97e-07	198	73	6	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PIK3C2B SPTB ZNF521 NOS3 CCDC85A	4.82e-06	150	73	5	4f31867cb85253ff6d22f3b02ef972a42cb41123
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Tfh\|Liver / Manually curated celltypes from each tissue	ABCA3 ANK3 GRB10 ANKRD18A ATL1	5.84e-06	156	73	5	85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STARD8 PIK3C2B SPTBN1 GRB10 CCDC85A	8.61e-06	169	73	5	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PIK3C2B FRYL SOX13 NOS3 CCDC85A	1.14e-05	179	73	5	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACTIN TONSL GCNT2 DNAH8 SOX13	1.20e-05	181	73	5	709e9c7a60d5f98635b99895ce30bb87a9f7376d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACTIN WDR87 HLA-DRB1 GCNT2 DNAH8	1.33e-05	185	73	5	3563dd39ec58d3273f95f5bb36b9ccdc0aafb63a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 ZNF521 GRB10 NOS3 RASAL2	1.40e-05	187	73	5	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTBN1 GRB10 NOS3 CCDC85A RASAL2	1.48e-05	189	73	5	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	droplet-Limb_Muscle-nan-3m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDM5C CEP250 NLRC5 RND2 GCNT2	1.48e-05	189	73	5	16a4c92dd7a0d60f3691bd3130a091a9a54730f1
ToppCell	facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP FRY PIK3C2B NOS3 CCDC85A	1.52e-05	190	73	5	89d1d686cc683206534e2157554d7d0df5d53497
ToppCell	facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP FRY PIK3C2B NOS3 CCDC85A	1.52e-05	190	73	5	65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PIK3C2B SPTBN1 ZNF521 CCDC85A RASAL2	1.52e-05	190	73	5	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 CCDC85A RASAL2	1.56e-05	191	73	5	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 ZNF521 NOS3 RASAL2	1.59e-05	192	73	5	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 ZNF521 NOS3 CCDC85A	1.59e-05	192	73	5	28eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP STARD8 PIK3C2B SPTBN1 RASAL2	1.63e-05	193	73	5	826b8dd801298b3e0cd76232feae5a14026b8806
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP STARD8 PIK3C2B SPTBN1 RASAL2	1.63e-05	193	73	5	87d3a577d37fb0cb4b6313c596310de452bc3872
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP STARD8 PIK3C2B SPTBN1 RASAL2	1.63e-05	193	73	5	d485634c564b268e344b6a2863c26f6adaec9e38
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 TRANK1 ANK3 PEG3 ACTN3	1.63e-05	193	73	5	1aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 GRB10 RASAL2	1.68e-05	194	73	5	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PIK3C2B ZNF521 GRB10 CCDC85A RASAL2	1.68e-05	194	73	5	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 ZNF521 CCDC85A RASAL2	1.68e-05	194	73	5	fa6d51f36a3dae8763a595c20892987ed454c0f0
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 PEG3 GRB10 ACTN3 ZHX2	1.76e-05	196	73	5	3dc6394c5de1f875a19ad0e8799827fad29f8f02
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B ZNF521 GRB10 NOS3 RASAL2	1.76e-05	196	73	5	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 SPTBN1 ZNF521 NOS3 RASAL2	1.76e-05	196	73	5	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 SPTBN1 ZNF521 NOS3 RASAL2	1.76e-05	196	73	5	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 NOS3 CCDC85A	1.76e-05	196	73	5	b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HLA-DRB1 SPTBN1 ZNF521 NOS3 RASAL2	1.76e-05	196	73	5	473980c827443464d08a0be28c53e3536369b12a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 NOS3 CCDC85A	1.76e-05	196	73	5	145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD8 HLA-DRB1 ZNF521 GRB10 NOS3	1.76e-05	196	73	5	e224338490691d92c1f70b57112fabdcc92b06a9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B SPTBN1 ZNF521 NOS3 CCDC85A	1.76e-05	196	73	5	d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD8 HLA-DRB1 ZNF521 GRB10 NOS3	1.80e-05	197	73	5	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 ZNF521 GRB10 NOS3 RASAL2	1.80e-05	197	73	5	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA3 ANK3 IRAG2 OGDHL GCNT2	1.80e-05	197	73	5	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	HLA-DRB1 GRB10 NOS3 CCDC85A RASAL2	1.80e-05	197	73	5	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD8 HLA-DRB1 ZNF521 GRB10 NOS3	1.80e-05	197	73	5	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 ZNF521 GRB10 NOS3 RASAL2	1.80e-05	197	73	5	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 GRB10 NOS3 CCDC85A RASAL2	1.85e-05	198	73	5	451003a21162eeae90739fdb502bb50b362d80c8
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 ZNF521 NOS3 CCDC85A	1.85e-05	198	73	5	953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 GRB10 NOS3 CCDC85A RASAL2	1.85e-05	198	73	5	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B HLA-DRB1 ZNF521 NOS3 CCDC85A	1.85e-05	198	73	5	8e45551224fbb30c0658ad47dd98335ecf165437
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRY ANK3 PEG3 RASAL2 CNTN1	1.85e-05	198	73	5	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	COVID-19_Mild-Neu_2\|World / 5 Neutrophil clusters in COVID-19 patients	KLHL11 ANK3 PIK3C2B DNAJC30	8.27e-05	140	73	4	b1429028c52f84127b894b93b55961badcd5246f
ToppCell	LPS-antiTNF-Myeloid-Myeloid_granulocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMEM132D KIAA2012 CNTN1 STRIP1	8.98e-05	143	73	4	4a0f26eef935fe68a1da5d319503059a8a8682dd
ToppCell	LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMEM132D KIAA2012 CNTN1 STRIP1	8.98e-05	143	73	4	65328a0a2f3972fac596e07933e74b2ef7cceb84
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC1\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WDR87 HLA-DRB1 MYO1F IRAG2	1.08e-04	150	73	4	3dc23a37dbeb7f9df93683702a7838f7cc3ec9cc
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MALRD1 TTLL11 SVIL KIAA2012	1.20e-04	154	73	4	6c1e7682c43c40b58b371c58deb10b839700ebcc
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANK3 WDR87 ALDH7A1 CNTN1	1.29e-04	157	73	4	6ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA3 MALRD1 ANK3 TMEM132D	1.35e-04	159	73	4	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 ANK3 SLC17A9 GCNT2	1.45e-04	162	73	4	8e0f03fcc25b2ea777e8478fbf771699cf93719c
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 ANK3 SLC17A9 GCNT2	1.45e-04	162	73	4	e0417f1242edf71934fe62bccc55c4678f7ff4ac
ToppCell	droplet-Limb_Muscle-nan-3m-Myeloid-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRANK1 IRAG2 ESPL1 KIAA2012	1.60e-04	166	73	4	0a7992bc673fca546636563ec3fc17a4298ab6b1
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP\|bone_marrow / Manually curated celltypes from each tissue	ZNF521 GRB10 OGDHL CNTN1	1.60e-04	166	73	4	9788486582cc2c5f28b9ea015e235732f9fefb1e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 BRAF KDM5C SPTBN1	1.63e-04	167	73	4	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PIGL GRB10 MAPK7 ATL1	1.67e-04	168	73	4	53a982869dbf14f6a948589be9f2f3df3b9a7e97
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	ABCA3 SPTB EMC2 ZHX2	1.67e-04	168	73	4	c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTB IRAG2 OGDHL CNTN1	1.75e-04	170	73	4	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ANK3 SPTBN1 CCDC85A RASAL2	1.75e-04	170	73	4	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	DAB2IP FRY PIK3C2B NOS3	1.87e-04	173	73	4	ec88e871b49331fca59bc610a8ae58e2d5e76bc1
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL11 PIK3C2B SCYL1 DNAH8	1.87e-04	173	73	4	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL11 PIK3C2B SCYL1 DNAH8	1.87e-04	173	73	4	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)\|368C / Donor, Lineage, Cell class and subclass (all cells)	DAB2IP FRY PIK3C2B NOS3	1.87e-04	173	73	4	22200fe74e33e2beae0eed289ca8476bbc0b1b2d
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DRB1 IRAG2 NLRC5 ZHX2	1.87e-04	173	73	4	67c342295b8a06ce38e081ba74478c568917a396
ToppCell	368C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SPTB ZNF521 KIAA2012 SOX13	1.87e-04	173	73	4	8cffb4a37d30b6626188309b868ac4a62e91262f
ToppCell	368C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SPTB ZNF521 KIAA2012 SOX13	1.87e-04	173	73	4	fb87ea74bf70aa83b458edf728c81857c8b8eb96
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DAB2IP FRY SPTB GRB10	1.91e-04	174	73	4	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	TMEM132D SPTBN1 GCNT2 CCDC85A	1.91e-04	174	73	4	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP SPTBN1 NOS3 CCDC85A	2.00e-04	176	73	4	fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8
ToppCell	facs-Heart-RV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP SPTBN1 NOS3 CCDC85A	2.00e-04	176	73	4	3270a36fc91a5583646ffeb70bfcbc5af7292aac
ToppCell	facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP SPTBN1 NOS3 CCDC85A	2.00e-04	176	73	4	99410c121f55adbc7fcc013c8fa8905a45dba76b
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP SPTBN1 NOS3 CCDC85A	2.04e-04	177	73	4	ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP SPTBN1 NOS3 CCDC85A	2.04e-04	177	73	4	f471f7747d6e8db7546899019af9508f48a14f89
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP SPTBN1 NOS3 CCDC85A	2.04e-04	177	73	4	cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK3 SVIL PEG3 CNTN1	2.04e-04	177	73	4	7af1a19692f7fe8f691178a4e57d62bc379e3d56
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DRB1 MYO1F IRAG2 NLRC5	2.04e-04	177	73	4	ecd26d086c1aff3be442fcb055611a563ca034ef
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 DNAH8 RASAL2 ATL1	2.13e-04	179	73	4	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP PIK3C2B SPTBN1 RASAL2	2.17e-04	180	73	4	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2IP PIK3C2B SPTBN1 RASAL2	2.17e-04	180	73	4	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL11 SPTB PEG3 CCDC85A	2.17e-04	180	73	4	79c5725f02e038d0187f4a1e1591f2492538aa57
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2B DIDO1 FRYL NOS3	2.22e-04	181	73	4	4ea02344e1996f264dd5e14f3b19c8782ce41699
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	ABCA3 ANK3 SPTBN1 CCDC85A	2.32e-04	183	73	4	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF521 GRB10 NOS3 RASAL2	2.32e-04	183	73	4	dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF521 GRB10 NOS3 RASAL2	2.32e-04	183	73	4	4759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CACTIN SLC17A9 DSN1 ALDH7A1	2.32e-04	183	73	4	dd15e1463a0d57d14800de0df0645c81c56926ae
Drug	Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	PIGL COPA INPP4A KDM5C SSX2IP MAPK7 RASAL2	2.61e-06	193	72	7	7187_UP
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	SMG7 ANK3 COPA INPP4A SPTB SPTBN1 MAPK7	2.79e-06	195	72	7	7058_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	ZHX3 SMG7 INPP4A SPTBN1 MYO1F MAPK7 ALDH7A1	2.89e-06	196	72	7	5765_DN
Drug	NU1025; Up 200; 100uM; MCF7; HG-U133A	ALLC STARD8 INPP4A SPTB SPTBN1 MYO1F RND2	2.99e-06	197	72	7	313_UP
Drug	Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	ZHX3 COPA SPTBN1 MYO1F GRB10 GCNT2 MAPK7	3.19e-06	199	72	7	6212_UP
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	CACTIN COPA INPP4A MYO1F GCNT2 SOX13	3.27e-05	192	72	6	4496_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZHX3 PIGL INPP4A SSX2IP GRB10 SOX13	3.37e-05	193	72	6	1667_DN
Drug	Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A	ZHX3 CACTIN PIGL INPP4A SPTBN1 GRB10	3.47e-05	194	72	6	5342_UP
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; HL60; HT_HG-U133A	SMG7 COPA CEP250 SPTBN1 GCNT2 RASAL2	3.57e-05	195	72	6	3048_DN
Drug	Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CACTIN ABCA3 SPTBN1 OGDHL MAPK7 SOX13	3.57e-05	195	72	6	4813_UP
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A	CACTIN TRANK1 SPTBN1 MYO1F MAPK7 ALDH7A1	3.57e-05	195	72	6	6661_DN
Drug	2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A	ZHX3 INPP4A SPTBN1 MAPK7 ZHX2 ALDH7A1	3.67e-05	196	72	6	6934_UP
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; PC3; HT_HG-U133A	PIGL COPA INPP4A CEP250 SPTBN1 SSX2IP	3.67e-05	196	72	6	6354_DN
Drug	Clozapine [5786-21-0]; Down 200; 12.2uM; HL60; HT_HG-U133A	CACTIN PIGL FRY COPA INPP4A SVIL	3.67e-05	196	72	6	1289_DN
Drug	Ge 3	TMEM132D SPTBN1 ALDH7A1	3.87e-05	21	72	3	CID000444690
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ZHX3 PIGL SMG7 SPTBN1 SSX2IP RND2	3.89e-05	198	72	6	6497_DN
Drug	Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A	CACTIN MYO1F IRAG2 RND2 GCNT2 ALDH7A1	3.89e-05	198	72	6	4999_UP
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A	ZHX3 COPA INPP4A SPTBN1 MYO1F RND2	4.00e-05	199	72	6	3444_UP
Drug	Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	BRAF INPP4A CEP250 OGDHL SOX13 DSN1	4.00e-05	199	72	6	3280_UP
Drug	Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CACTIN SMG7 BRAF SCMH1 KDM5C GRB10	4.00e-05	199	72	6	5535_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ZHX3 INPP4A SVIL MYO1F GRB10 RND2	4.00e-05	199	72	6	6006_DN
Drug	Pentylenetetrazole [54-95-5]; Up 200; 29uM; PC3; HT_HG-U133A	ABCA3 INPP4A KDM5C SPTB MAPK7 SOX13	4.00e-05	199	72	6	2092_UP
Drug	Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A	COPA KDM5C MYO1F GCNT2 MAPK7 RASAL2	4.11e-05	200	72	6	1674_UP
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	SLC17A9 INPP4A CEP250 SPTBN1 MAPK7 ZHX2	4.11e-05	200	72	6	3097_DN
Drug	EU m	ESPL1 ALDH7A1	9.80e-05	5	72	2	CID000205309
Drug	AC1L1KMJ	ANK3 SPTB SPTBN1 PEG3 SSX2IP PKD2 MAPK7 CNTN1	1.28e-04	476	72	8	CID000030956
Drug	2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester	DAB2IP STARD8 ANK3 PEG3 SSX2IP FRYL ZHX2 NOS3 CCDC85A RASAL2	2.17e-04	807	72	10	ctd:C548651
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	ZHX3 FRY SPTBN1 GRB10 ZHX2	2.87e-04	183	72	5	2696_DN
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	ZHX3 CACTIN FRY SPTB OGDHL	3.02e-04	185	72	5	5935_UP
Drug	0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A	CACTIN SSX2IP MAPK7 ESPL1 DSN1	3.33e-04	189	72	5	7392_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ZHX3 PIGL INPP4A GRB10 RND2	3.50e-04	191	72	5	3605_DN
Drug	Rimexolone [49697-38-3]; Up 200; 10.8uM; HL60; HT_HG-U133A	ABCA3 SMG7 INPP4A SPTB SOX13	3.50e-04	191	72	5	2955_UP
Drug	Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; HL60; HT_HG-U133A	CACTIN BRAF INPP4A SPTBN1 GRB10	3.67e-04	193	72	5	3028_DN
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	SMG7 ANK3 COPA MAPK7 ALDH7A1	3.67e-04	193	72	5	4321_DN
Drug	Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A	ZHX3 SPTBN1 DIDO1 SOX13 RASAL2	3.67e-04	193	72	5	3474_UP
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	CACTIN CEP250 MYO1F PKD2 RND2	3.67e-04	193	72	5	5430_DN
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	PIGL SMG7 ANK3 SCMH1 SVIL	3.76e-04	194	72	5	5316_DN
Drug	semustine; Down 200; 100uM; PC3; HT_HG-U133A	INPP4A SPTB SVIL ESPL1 ALDH7A1	3.76e-04	194	72	5	7492_DN
Drug	NS-398; Up 200; 10uM; MCF7; HT_HG-U133A	ANK3 COPA INPP4A MYO1F ALDH7A1	3.76e-04	194	72	5	6897_UP
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A	CACTIN CEP250 MYO1F GRB10 RND2	3.76e-04	194	72	5	5454_DN
Drug	Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A	CACTIN INPP4A SPTBN1 MYO1F NOS3	3.76e-04	194	72	5	3556_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A	ZHX3 INPP4A SPTB SVIL SOX13	3.76e-04	194	72	5	4291_DN
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A	ZHX3 CACTIN SMG7 INPP4A SVIL	3.85e-04	195	72	5	1296_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	INPP4A GCNT2 SOX13 ALDH7A1 RASAL2	3.85e-04	195	72	5	2283_DN
Drug	aspirin, USP; Down 200; 100uM; PC3; HT_HG-U133A	COPA INPP4A SPTB SPTBN1 PEG3	3.85e-04	195	72	5	4428_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	ZHX3 ABCA3 PEG3 MYO1F DIDO1	3.85e-04	195	72	5	7318_UP
Drug	Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A	CACTIN PIGL TRANK1 SVIL MAPK7	3.85e-04	195	72	5	2475_DN
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A	ZHX3 SMG7 INPP4A OGDHL MAPK7	3.85e-04	195	72	5	3806_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	ZHX3 CACTIN INPP4A SSX2IP RND2	3.85e-04	195	72	5	7172_DN
Drug	Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CACTIN PIK3C2B SCMH1 SPTBN1 SVIL	3.85e-04	195	72	5	4784_DN
Drug	SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A	STARD8 COPA SPTBN1 SSX2IP MAPK7	3.94e-04	196	72	5	6887_UP
Drug	Niflumic acid [4394-00-7]; Down 200; 14.2uM; PC3; HT_HG-U133A	CACTIN ABCA3 INPP4A CEP250 PEG3	3.94e-04	196	72	5	5071_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CACTIN CEP250 GCNT2 MAPK7 CNTN1	3.94e-04	196	72	5	6065_DN
Drug	rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	ZHX3 CACTIN SMG7 BRAF COPA	3.94e-04	196	72	5	921_DN
Drug	Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ZHX3 SMG7 CEP250 SPTBN1 MAPK7	3.94e-04	196	72	5	3461_UP
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ZHX3 PIGL SMG7 SPTBN1 SSX2IP	3.94e-04	196	72	5	7175_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A	COPA CEP250 SPTB MAPK7 CNTN1	3.94e-04	196	72	5	4467_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A	PIGL MYO1F MAPK7 ALDH7A1 RASAL2	3.94e-04	196	72	5	1708_UP
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CACTIN ANK3 KDM5C MAPK7 SOX13	3.94e-04	196	72	5	1684_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	ZHX3 COPA CEP250 GRB10 RND2	3.94e-04	196	72	5	4747_DN
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; HL60; HT_HG-U133A	SMG7 ANK3 PIK3C2B ZHX2 SOX13	3.94e-04	196	72	5	1333_UP
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CACTIN INPP4A GCNT2 SOX13 RASAL2	4.03e-04	197	72	5	5400_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	ZHX3 CACTIN CEP250 MAPK7 RASAL2	4.03e-04	197	72	5	4135_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ZHX3 CACTIN INPP4A CEP250 ALDH7A1	4.03e-04	197	72	5	6012_DN
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HT_HG-U133A	SMG7 COPA CEP250 SPTBN1 MAPK7	4.03e-04	197	72	5	6700_DN
Drug	Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A	CACTIN SMG7 KDM5C SSX2IP PKD2	4.03e-04	197	72	5	3439_DN
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	CACTIN PIGL ANK3 SSX2IP SOX13	4.03e-04	197	72	5	5463_DN
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	KDM5C SPTBN1 MYO1F GCNT2 ALDH7A1	4.03e-04	197	72	5	3894_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ZHX3 CACTIN SMG7 SPTBN1 SOX13	4.03e-04	197	72	5	2643_DN
Drug	Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; PC3; HT_HG-U133A	CACTIN SMG7 BRAF CEP250 ZHX2	4.03e-04	197	72	5	5886_DN
Drug	Evoxine [522-11-2]; Up 200; 11.6uM; HL60; HT_HG-U133A	ANK3 INPP4A CEP250 PEG3 MAPK7	4.03e-04	197	72	5	2186_UP
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	ZHX3 SMG7 SVIL ALDH7A1 RASAL2	4.03e-04	197	72	5	3723_DN
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; MCF7; HT_HG-U133A	CACTIN SMG7 SCMH1 RND2 SOX13	4.03e-04	197	72	5	1497_DN
Drug	Nimodipine [66085-59-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	CACTIN SMG7 KDM5C MAPK7 ALDH7A1	4.03e-04	197	72	5	6320_DN
Drug	Fosfosal [6064-83-1]; Down 200; 18.4uM; MCF7; HT_HG-U133A	ANK3 CEP250 SPTBN1 GRB10 CNTN1	4.03e-04	197	72	5	3336_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZHX3 KDM5C GRB10 RND2 RASAL2	4.03e-04	197	72	5	5576_DN
Drug	Sulfachloropyridazine [80-32-0]; Up 200; 14uM; MCF7; HT_HG-U133A	ALLC TRANK1 INPP4A CEP250 MAPK7	4.03e-04	197	72	5	6046_UP
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SCMH1 INPP4A SPTBN1 GRB10 GCNT2	4.03e-04	197	72	5	3456_DN
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	CACTIN PIGL BRAF INPP4A MYO1F	4.03e-04	197	72	5	7483_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	PIGL ABCA3 PKD2 RND2 SOX13	4.03e-04	197	72	5	7171_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	CACTIN SPTB RND2 MAPK7 CNTN1	4.03e-04	197	72	5	5605_UP
Drug	Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; MCF7; HT_HG-U133A	CACTIN INPP4A KDM5C MYO1F SOX13	4.03e-04	197	72	5	2782_DN
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A	CACTIN SMG7 SVIL SSX2IP GRB10	4.03e-04	197	72	5	3417_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	CACTIN BRAF DIDO1 FRYL MAPK7	4.03e-04	197	72	5	2070_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	CACTIN BRAF KDM5C PKD2 DIDO1	4.03e-04	197	72	5	6974_DN
Drug	Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	INPP4A CEP250 MAPK7 SOX13 DSN1	4.13e-04	198	72	5	3276_UP
Drug	novobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A	ANK3 INPP4A SSX2IP GRB10 DSN1	4.13e-04	198	72	5	437_UP
Drug	5155877; Down 200; 10uM; PC3; HT_HG-U133A	PIGL SMG7 INPP4A CEP250 SOX13	4.13e-04	198	72	5	6544_DN
Drug	Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A	ZHX3 GRB10 GCNT2 MAPK7 CNTN1	4.13e-04	198	72	5	3356_DN
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; HL60; HT_HG-U133A	SLC17A9 PIK3C2B INPP4A SSX2IP MAPK7	4.13e-04	198	72	5	3087_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; HL60; HT_HG-U133A	TRANK1 ANK3 SPTBN1 GCNT2 CNTN1	4.13e-04	198	72	5	2526_UP
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SMG7 INPP4A MYO1F GRB10 SOX13	4.13e-04	198	72	5	3441_DN
Drug	Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; MCF7; HT_HG-U133A	BRAF PIK3C2B SVIL GRB10 SOX13	4.13e-04	198	72	5	7240_DN
Drug	PNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A	KDM5C SPTB MYO1F ALDH7A1 RASAL2	4.13e-04	198	72	5	3632_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A	ZHX3 INPP4A KDM5C SVIL SOX13	4.13e-04	198	72	5	7168_DN
Drug	Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A	ABCA3 INPP4A MAPK7 ALDH7A1 CNTN1	4.13e-04	198	72	5	3286_UP
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ZHX3 INPP4A KDM5C MAPK7 SOX13	4.13e-04	198	72	5	3175_DN
Drug	Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SMG7 SCMH1 INPP4A CEP250 SSX2IP	4.13e-04	198	72	5	7031_DN
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	COPA KDM5C DIDO1 MAPK7 RASAL2	4.13e-04	198	72	5	4979_DN
Drug	Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	ZHX3 CACTIN INPP4A SPTBN1 MYO1F	4.13e-04	198	72	5	5876_UP
Disease	spinocerebellar ataxia type 5 (implicated_via_orthology)	SPTB SPTBN1	3.41e-05	4	71	2	DOID:0050882 (implicated_via_orthology)
Disease	vulva cancer (is_implicated_in)	HLA-DRB1 NOS3	3.41e-05	4	71	2	DOID:1245 (is_implicated_in)
Disease	extranodal nasal NK/T cell lymphoma	HLA-DRB1 HLA-DRB3	8.51e-05	6	71	2	MONDO_0019472
Disease	retinopathy of prematurity (is_implicated_in)	HLA-DRB1 NOS3	1.19e-04	7	71	2	DOID:13025 (is_implicated_in)
Disease	hydroxy-leucine measurement	DAB2IP TTLL11 CNTN1	1.76e-04	45	71	3	EFO_0005276
Disease	response to vaccine	HLA-DRB1 HLA-DRB3 ZHX2 RASAL2	2.18e-04	122	71	4	EFO_0004645
Disease	aspirin-induced respiratory disease (is_implicated_in)	HLA-DRB1 HLA-DRB3	3.10e-04	11	71	2	DOID:0080822 (is_implicated_in)
Disease	Oligospermia	NOS3 PIWIL3	3.71e-04	12	71	2	C0028960
Disease	temporal arteritis	RSBN1 HLA-DRB1	3.71e-04	12	71	2	EFO_1001209
Disease	migraine disorder, type 2 diabetes mellitus	ZHX3 FRYL KIAA2012	4.14e-04	60	71	3	MONDO_0005148, MONDO_0005277
Disease	bipolar disorder	TRANK1 ANK3 BRAF INPP4A ACTN3 RASAL2 CNTN1	4.75e-04	577	71	7	MONDO_0004985
Disease	rheumatoid arthritis, COVID-19	RSBN1 HLA-DRB1 FRYL	5.01e-04	64	71	3	EFO_0000685, MONDO_0100096
Disease	hearing loss	HLA-DRB1 SPTBN1 GRB10	5.73e-04	67	71	3	EFO_0004238
Disease	cleft lip	FRY TMEM132D HLA-DRB3 SVIL CCDC85A	6.18e-04	284	71	5	EFO_0003959
Disease	gout, hyperuricemia	MALRD1 PKD2	6.70e-04	16	71	2	EFO_0004274, EFO_0009104
Disease	mean platelet volume	RSBN1 FRY TRANK1 STARD8 SPTBN1 SVIL FRYL ESPL1 NOS3	7.41e-04	1020	71	9	EFO_0004584
Disease	hepatocellular carcinoma (is_marker_for)	DAB2IP KDM5C NLRC5 DSN1 ALDH7A1	8.03e-04	301	71	5	DOID:684 (is_marker_for)
Disease	Manic	TRANK1 ANK3 DNAH8	8.92e-04	78	71	3	C0338831
Disease	hepatitis B virus infection	HLA-DRB1 HLA-DRB3	9.51e-04	19	71	2	EFO_0004197
Disease	leptin measurement	HLA-DRB1 SPTB DNAH8	9.96e-04	81	71	3	EFO_0005000
Disease	diastolic blood pressure, systolic blood pressure	PIGL MALRD1 ANK3 SLC7A6OS SVIL SCYL1 GRB10	1.14e-03	670	71	7	EFO_0006335, EFO_0006336
Disease	Immunosuppressant use measurement	RSBN1 HLA-DRB1	1.16e-03	21	71	2	EFO_0009934
Disease	Henoch-Schoenlein purpura	MALRD1 HLA-DRB1	1.28e-03	22	71	2	EFO_1000965
Disease	Lymphoma, Non-Hodgkin, Familial	BRAF HLA-DRB1	1.28e-03	22	71	2	C4721532
Disease	Colorectal Carcinoma	ABCA3 STARD8 BRAF PEG3 DNAH8 RASAL2 CNTN1	1.49e-03	702	71	7	C0009402
Disease	Cholangiocarcinoma	BRAF PEG3	1.79e-03	26	71	2	C0206698

Protein segments in the cluster

Peptide	Gene	Start	Entry
NRMKTLGRRDSSDDW	BRAF	436	P15056
DSQRNKERTRFTWMD	LINC00242	71	Q5T6M2
LWRADDVSRHEKMGS	ANKRD18A	446	Q8IVF6
EQMRSKGNRDRPWSN	CDC42SE1	61	Q9NRR8
RESGSDAWKQYMRRS	ALDH7A1	506	P49419
GAKSMADGWETARRL	ALLC	226	Q8N6M5
SWRTGKTEARNEDEM	SSX2IP	241	Q9Y2D8
DKWNSRSRFLSGGMR	ABCA3	656	Q99758
LRVLSSWREDSMDRK	CST9	71	Q5W186
DQDTLMARWTGRNSR	INPP4A	501	Q96PE3
SAAERDKWMENLRRA	DAB2IP	186	Q5VWQ8
LSDNDRSLLERWTRM	MAPK7	561	Q13164
GNLRAIKWSDMEDRH	GCNT2	321	Q8N0V5
LRGRADMTKNRTVDW	OGDHL	626	Q9ULD0
DGAAWDRRNGKLMES	DNAH8	4406	Q96JB1
ESMDNFNWGVRRRSL	FRYL	2441	O94915
NSASERDKWMENLRR	RASAL2	141	Q9UJF2
EKASWDRLRAERAEM	KIAA2012	981	Q0VF49
DRRREWAALGNMSKE	ACBD3	141	Q9H3P7
DTRQASNRWEKRAME	DNAJC21	171	Q5F1R6
DRSQRFPRMSDDNWK	PEG3	336	Q9GZU2
LRGDKTSRDMWATGS	NLRC5	1076	Q86WI3
WRRKRKESSNTDSAG	NOS3	626	P29474
AEMLRDATRGWKEGR	PIK3C2B	246	O00750
RGDKAHFRSTMWRES	MALRD1	1576	Q5VYJ5
EWRARSESAQSKMLS	HLA-DRB3	216	P79483
NWRKMSFEILRGSDG	ESPL1	1496	Q14674
SESRSGRVEMRKWSS	KLHL11	131	Q9NVR0
MAKNRRDRNSWGGFS	ATL1	1	Q8WXF7
WDMSKRTGVQTFRRD	COPA	276	P53621
KWRMNNGDVDLTSDR	CNTN1	76	Q12860
SRARDELMRKESQWQ	CEP250	146	Q9BV73
DRRQSWRRASMKETN	DSN1	91	Q9H410
KDSSRDWDRNRERSA	DIDO1	2141	Q9BTC0
EWRARSESAQSKMLS	HLA-DRB1	216	P01911
WMRFTEDRLDRGREK	ANK3	2556	Q12955
NSSNMEKGWGSRARR	CCDC85A	451	Q96PX6
GMENNDRFSRRSSSW	IRAG2	391	Q12912
LEEGHAWRKRSTRMN	GRB10	456	Q13322
RSDSEEERWQRSGMR	CACTIN	56	Q8WUQ7
RDKMRKWREENSRNS	EMC2	16	Q15006
MDNFNWGVRRRSLDS	FRY	2476	Q5TBA9
RSMKGLRWEDTRDTA	DNAJC30	196	Q96LL9
RRMVKANSQGDWSRE	PIWIL3	481	Q7Z3Z3
TDWADRDNGEMRRKT	NLGN2	436	Q8NFZ4
MFISGRRTADKWRAE	RSBN1	1	Q5VWQ0
SARIRWASDRKSAME	SVIL	2071	O95425
IMGRDWDDRSAGEKL	TMEM132D	151	Q14C87
DSSGRVVREKWSADM	SCYL1	191	Q96KG9
VWDSSERMKSREQGG	PIGL	21	Q9Y2B2
DNRDRRTADRWKTDK	SMG7	1036	Q92540
GDKAEWRTMRQTFRA	STRIP1	236	Q5VSL9
DEARRDMAGDTQWSR	SLC17A9	6	Q9BYT1
DLLRDAAERFKGWMS	STARD8	826	Q92502
VLKGSNERRDMESFW	SCMH1	551	Q96GD3
NERRDMESFWKLNRS	SCMH1	556	Q96GD3
RFDRKAAMRETWLSE	SPTBN1	426	Q01082
EAWTRGKEEMLSQRD	ACTN3	421	Q08043
EEERGSSRQRMWSKY	SLC7A6OS	276	Q96CW6
DKRRIELNMWDTSGS	RND2	51	P52198
AWTKRNDMRLDSEGI	TRIM77	361	I1YAP6
MRRGSSESELAARWE	TTLL11	91	Q8NHH1
SDWKERFLGRNSMEA	SOX13	121	Q9UN79
ASQMRESWRHKAGRR	ZSCAN5DP	31	P0CG00
RRKGSKWNRRNDMGE	TONSL	516	Q96HA7
RNKDGSQSGSRMEDW	ZNF521	226	Q96K83
RFDRKAAMRETWLSE	SPTB	426	P11277
WGTRLMEESSTNREK	PKD2	201	Q13563
WFSERRKLRDSMEQA	ZHX2	576	Q9Y6X8
DSRQLASGGWDKRVM	WDR38	116	Q5JTN6
ARNRRESTDLWLSAM	TRANK1	2276	O15050
RSETKMTRREIDSWF	ZHX3	646	Q9H4I2
MTRREIDSWFSERRK	ZHX3	651	Q9H4I2
LTDGANRSWLGRKMS	WDR87	861	Q6ZQQ6
ADAGSDSTKRSRWME	KDM5C	1106	P41229
LTSRKMDSRWGGRSE	MYO1F	321	O00160